Stay updated on Neurobiol Basis of Response to Vyvanse in Adults With ADHD: Clinical Trial
Sign up to get notified when there's something new on the Neurobiol Basis of Response to Vyvanse in Adults With ADHD: Clinical Trial page.

Latest updates to the Neurobiol Basis of Response to Vyvanse in Adults With ADHD: Clinical Trial page
- Check3 days agoChange DetectedThe study record describes a completed Phase 4 trial investigating how Vyvanse affects brain activity in adults with ADHD, including its design, eligibility criteria, outcome measures, and related publications.SummaryDifference47%

- Check10 days agoChange DetectedThe site footer now shows revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe study record page displays a 403 Forbidden message, while a site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference2%

- Check31 days agoChange DetectedThe 403 Forbidden message and its Home link are no longer displayed, leaving the area beneath the navigation blank.SummaryDifference0.5%

- Check38 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe study record page now displays a 403 Forbidden screen with minimal navigation (Home), and the previous study details and related metadata have been removed.SummaryDifference18%

Stay in the know with updates to Neurobiol Basis of Response to Vyvanse in Adults With ADHD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neurobiol Basis of Response to Vyvanse in Adults With ADHD: Clinical Trial page.